Home Applications 215211 Application 215211
Type NDA
Sponsor AMICUS THERAP US Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 OPFOLDA MIGLUSTAT CAPSULE;ORAL 65MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N215211-001 OPFOLDA MIGLUSTAT 65MG CAPSULE / ORAL RLD, RS 2023-09-28
Orange Book patents# Current patent rows page 1 of 1 · 10 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N215211-001 10512677 2033-03-07 U-3726 2023-10-26 N215211-001 11278599 2033-03-07 U-3726 2023-10-26 N215211-001 12419937 2033-03-07 U-3726 2025-10-21 N215211-001 10208299 2035-09-30 U-3726 Drug substance, Drug product 2023-10-26 N215211-001 10961522 2035-09-30 U-3726 2023-10-26 N215211-001 11753632 2035-09-30 U-3726 2023-10-26 N215211-001 11278601 2036-12-29 U-3726 Drug product 2023-10-26 N215211-001 12414985 2036-12-29 U-3726 2025-10-21 N215211-001 10857212 2037-08-12 U-3726 2023-10-26 N215211-001 12246062 2038-09-16 U-3726 2025-03-18
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N215211-001 NP 2026-09-28
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N215211-001 OPFOLDA 65MG CAPSULE / ORAL RLD, RS 2023-09-28 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N215211-001 OPFOLDA 65MG CAPSULE / ORAL RLD, RS 2023-09-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215211-001 OPFOLDA 65MG CAPSULE / ORAL RLD, RS 2023-09-28 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N215211-001 OPFOLDA 65MG CAPSULE / ORAL RLD, RS 2023-09-28 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215211-001 OPFOLDA 65MG CAPSULE / ORAL RLD, RS 2023-09-28 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N215211-001 OPFOLDA 65MG CAPSULE / ORAL RLD, RS 2023-09-28 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N215211-001 OPFOLDA 65MG CAPSULE / ORAL RLD, RS 2023-09-28 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N215211-001 OPFOLDA 65MG CAPSULE / ORAL RLD, RS 2023-09-28 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N215211-001 OPFOLDA 65MG CAPSULE / ORAL RLD, RS 2023-09-28 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N215211-001 OPFOLDA 65MG CAPSULE / ORAL RLD, RS 2023-09-28 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N215211-001 OPFOLDA 65MG CAPSULE / ORAL RLD, RS 2023-09-28 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N215211-001 OPFOLDA 65MG CAPSULE / ORAL RLD, RS 2023-09-28 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N215211-001 OPFOLDA 65MG CAPSULE / ORAL RLD, RS 2023-09-28 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N215211-001 OPFOLDA 65MG CAPSULE / ORAL RLD, RS 2023-09-28 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N215211-001 OPFOLDA 65MG CAPSULE / ORAL RLD, RS 2023-09-28 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N215211-001 OPFOLDA 65MG CAPSULE / ORAL RLD, RS 2023-09-28 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N215211-001 OPFOLDA 65MG CAPSULE / ORAL RLD, RS 2023-09-28 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N215211-001 OPFOLDA 65MG CAPSULE / ORAL RLD, RS 2023-09-28 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N215211-001 OPFOLDA 65MG CAPSULE / ORAL RLD, RS 2023-09-28 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N215211-001 OPFOLDA 65MG CAPSULE / ORAL RLD, RS 2023-09-28 9b2671bbb829…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215211-001 OPFOLDA 65MG CAPSULE / ORAL RLD, RS 2023-09-28 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 4 · 153 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N215211-001 10512677 2033-03-07 U-3726 2023-10-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215211-001 11278599 2033-03-07 U-3726 2023-10-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215211-001 12419937 2033-03-07 U-3726 2025-10-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215211-001 10208299 2035-09-30 U-3726 Drug substance, Drug product 2023-10-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215211-001 10961522 2035-09-30 U-3726 2023-10-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215211-001 11753632 2035-09-30 U-3726 2023-10-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215211-001 11278601 2036-12-29 U-3726 Drug product 2023-10-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215211-001 12414985 2036-12-29 U-3726 2025-10-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215211-001 10857212 2037-08-12 U-3726 2023-10-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215211-001 12246062 2038-09-16 U-3726 2025-03-18 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N215211-001 10512677 2033-03-07 U-3726 2023-10-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215211-001 11278599 2033-03-07 U-3726 2023-10-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215211-001 12419937 2033-03-07 U-3726 2025-10-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215211-001 10208299 2035-09-30 U-3726 Drug substance, Drug product 2023-10-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215211-001 10961522 2035-09-30 U-3726 2023-10-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215211-001 11753632 2035-09-30 U-3726 2023-10-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215211-001 11278601 2036-12-29 U-3726 Drug product 2023-10-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215211-001 12414985 2036-12-29 U-3726 2025-10-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215211-001 10857212 2037-08-12 U-3726 2023-10-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215211-001 12246062 2038-09-16 U-3726 2025-03-18 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215211-001 10512677 2033-03-07 U-3726 2023-10-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215211-001 11278599 2033-03-07 U-3726 2023-10-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215211-001 12419937 2033-03-07 U-3726 2025-10-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215211-001 10208299 2035-09-30 U-3726 Drug substance, Drug product 2023-10-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215211-001 10961522 2035-09-30 U-3726 2023-10-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215211-001 11753632 2035-09-30 U-3726 2023-10-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215211-001 11278601 2036-12-29 U-3726 Drug product 2023-10-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215211-001 12414985 2036-12-29 U-3726 2025-10-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215211-001 10857212 2037-08-12 U-3726 2023-10-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215211-001 12246062 2038-09-16 U-3726 2025-03-18 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N215211-001 10512677 2033-03-07 U-3726 2023-10-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215211-001 11278599 2033-03-07 U-3726 2023-10-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215211-001 10208299 2035-09-30 U-3726 Drug substance, Drug product 2023-10-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215211-001 10961522 2035-09-30 U-3726 2023-10-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215211-001 11753632 2035-09-30 U-3726 2023-10-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215211-001 11278601 2036-12-29 U-3726 Drug product 2023-10-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215211-001 10857212 2037-08-12 U-3726 2023-10-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215211-001 12246062 2038-09-16 U-3726 2025-03-18 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215211-001 10512677 2033-03-07 U-3726 2023-10-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215211-001 11278599 2033-03-07 U-3726 2023-10-26 fd3edfee7708…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join OPFOLDA MIGLUSTAT AMICUS THERAPEUTICS US, LLC d7c38298-37db-5a80-e053-2995a90aee40 2024-11-27 Warnings, Adverse reactions Exact identifier application applno (NDA): 215211 application number: NDA215211
Documents# Document, Submission type, Date table Document Submission type Date 79239 SUPPL 2024-07-29 79217 SUPPL 2024-07-26 75990 ORIG 2023-10-31 75620 ORIG 2023-09-29 75601 ORIG 2023-09-28